Ambros Therapeutics News and Activities

View the org chart displaying its 12 main executives

Most searched biographies at Ambros Therapeutics

• Joseph Hagan, Chief Executive Officer
• Vivek Ramaswamy, Director
• Prisca Di Martino, Director

Popular executive movements at Ambros Therapeutics

• Claire Padgett has joined the company as Senior Vice President of Clinical Operations and Program Management  (posted on June 15 2026).
• Cris Calsada has joined the company as Chief Financial Officer  (posted on June 15 2026).

Create your alert
to follow the executive moves at Ambros Therapeutics.

Ambros Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Ambros Therapeutics

• Ambros Therapeutics Appoints Cris Calsada as Chief Financial Officer and Claire Padgett, Ph.D., as SVP of Clinical Operations and Program Management - Ambros Therapeutics, Inc.
• Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1 - Ambros Therapeutics, Inc.
• Ambros Therapeutics Announces Notice of Allowance for New U.S. Patent Application Covering Neridronate for Complex Regional Pain Syndrome Type 1 - Ambros Therapeutics, Inc.
• Ambros Therapeutics Launches with $125 Million Series A Financing to Advance Neridronate Through Phase 3 Registrational Program for Complex Regional Pain Syndrome Type 1 - Ambros Therapeutics, Inc.
• News - Ambros Therapeutics, Inc.

Social media about Ambros Therapeutics

• Ambros Therapeutics on Wikipedia, Google News & Yahoo Finance
• Ambros Therapeutics on LinkedIn, X (Twitter) & YouTube